Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Accounts Payable & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Accounts Payable

LCTX Accounts Payable

Latest reported$2.34Mperiod endingDec 31, 2025

LCTX FY Accounts Payable ($0.00 → $2.34M)

Annual accounts payable

High-resolution chart · PNG

LCTX accounts payable history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Accounts Payable — Annual fiscal periods (USD)
Period ending	Accounts Payable (USD)
Dec 31, 2025	2,341,000
Dec 31, 2024	1,174,000
Dec 31, 2023	2,050,000
Dec 31, 2022	2,393,000
Dec 31, 2021	3,543,000
Dec 31, 2020	2,611,000
Dec 31, 2019	2,427,000
Dec 31, 2018	2,359,000
Dec 31, 2017	938,000
Dec 31, 2016	1,593,000
Dec 31, 2015	2,798,000
Dec 31, 2014	2,297,000
Dec 31, 2013	3,434,748
Dec 31, 2012	1,168,077
Dec 31, 2011	1,118,112
Dec 31, 2010	0
Dec 31, 2009	0
Dec 31, 2008	0
Dec 31, 2007	480,374
Dec 31, 2006	431,713
Dec 31, 2005	566,597
Dec 31, 2004	275,256
Dec 31, 2003	408,891
Dec 31, 2002	358,000
Dec 31, 2001	309,347
Dec 31, 2000	359,749
Dec 31, 1999	595,512
Dec 31, 1998	200,000
Jun 30, 1998	300,000
Jun 30, 1996	200,000
Jun 30, 1995	100,000
Jun 30, 1994	300,000
Jun 30, 1993	0
Jun 30, 1992	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.